Publications by authors named "Hou JinLin"

Claim this Profile
D
Dynamics of Serum Hepatitis B Virus Nucleic Acids in Patients With Chronic Hepatitis B After Stopping Nucleos(t)ide Analogs Reveal Delayed Rebound of Hepatitis B Virus RNA.
Wanying Li, Rui Deng, Rong Fan, Xieer Liang, Xingyu Lu, Jinlin Hou

J Med Virol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Corrigendum] Reactive oxygen species‑mediated activation of the Src‑epidermal growth factor receptor‑Akt signaling cascade prevents bortezomib‑induced apoptosis in hepatocellular carcinoma cells.
Jinlin Hou, Anguo Cui, Peiying Song, Hui Hua, Ting Luo

Mol Med Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition).
Jian Zhou, Huichuan Sun, Zheng Wang, Wenming Cong, Mengsu Zeng, Jinlin Hou

Liver Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of GST-HG141, a novel HBV capsid assembly modulator, for the treatment of chronic hepatitis B patients with low-level viremia: a randomized, double-blind, placebo-controlled, multicenter phase II study.
Chong Wang, Fei Kong, Haibing Gao, Dachuan Cai, Guoqiang Zhang, Jinlin Hou

EClinicalMedicine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular Carcinoma Risk Stratification for Cirrhosis Patients: Integrating Radiomics and Deep Learning Computed Tomography Signatures of the Liver and Spleen into a Clinical Model.
Rong Fan, Ya-Ru Shi, Lei Chen, Chuan-Xin Wang, Yun-Song Qian

J Clin Transl Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver-Related Events in Nucleos(t)ide Analogue-Treated Chronic Hepatitis B Patients in China.
Rong Fan, Ning Yu, Jimmy Che-To Lai, Vicki Wing-Ki Hui, Jie Peng, Jinlin Hou

Aliment Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Pre-activation of toll-like receptor 2 enhances CD8+ T-cell responses and accelerates hepatitis B virus clearance in the mouse models.
Yong Lin, Xuan Huang, Jun Wu, Jia Liu, Mingfa Chen, Jinlin Hou

Front Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCR-based cellular immunotherapy for hepatocellular carcinoma: advances, challenges, and prospects.
Wanting Zeng, Wei Zhu, Guosheng Yuan, Jinzhang Chen, Zhanhui Wang, Jinlin Hou

Cancer Immunol Immunother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between HBsAg/HBV DNA and prognosis in patients with HBV-related hepatocellular carcinoma treated with PD-1/PD-L1 inhibitors.
Qiuying Qin, Yuanyuan Zheng, Yiran Wang, Fei Zhou, Dong Li, Jinlin Hou

Ther Adv Med Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Validation of the GOLDEN Model for Predicting HBsAg Loss in Noncirrhotic Chronic Hepatitis B Patients With Interferon-Alpha-Based Therapy.
Xingmei Liao, Qing Xie, Xiaoguang Dou, Junqi Niu, Hong Ma, Jinlin Hou

Clin Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Hepatitis D Virus Antibody Positivity in Chinese Patients with Chronic Hepatitis B Virus Infection.
Xieer Liang, Qiaoqiao Chen, Hong Tang, Yujuan Guan, Minfeng Liang, Jinlin Hou

J Clin Transl Hepatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trial.
Mingyuan Zhang, Yanhang Gao, Fei Kong, Haibing Gao, Yongxiang Yi, Jinlin Hou

J Infect· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-chain acylcarnitine deficiency promotes hepatocarcinogenesis.
Kaifeng Wang, Zhixian Lan, Heqi Zhou, Rong Fan, Huiyi Chen, Jinlin Hou

Acta Pharm Sin B· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Early On-Treatment Serum HBV RNA Declines in Predicting Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis B.
Shi Liu, Grace Lai-Hung Wong, Rong Fan, Junqi Niu, Hong Ma, Jinlin Hou

Clin Gastroenterol Hepatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum ECM1 is a promising biomarker for staging and monitoring fibrosis in patients with chronic hepatitis B.
Lian Liu, Danyan Zhang, Rong Fan, Shipeng Cheng, Jichao Yang, Jinlin Hou

Sci China Life Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies.
Jinlin Hou, Thomas Berg, Arndt Vogel, Teerha Piratvisuth, Jörg Trojan

JHEP Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B. Reply.
Jinlin Hou, Farouk Chughlay, Rémi Kazma

N Engl J Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating HBsAg-specific B cells are partially rescued in chronically HBV-infected patients with functional cure.
Shuqin Gu, Libo Tang, Ling Guo, Chunxiu Zhong, Xin Fu, Jinling Wei, Jinlin Hou

Emerg Microbes Infect· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics, and antiviral efficacy of the novel capsid assembly modulator GST-HG141 in patients with chronic hepatitis B: a phase 1 trial with a randomized, placebo-controlled design.
Min Wu, Jiajia Mai, Hong Zhang, George Zhang, John Mao, Jinlin Hou

Virol J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B.
Jinlin Hou, Wenhong Zhang, Qing Xie, Rui Hua, Hong Tang

N Engl J Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR7 genetic variant predicts treatment response of pegylated-interferon α in HBeAg-positive chronic hepatitis B patients.
Mengqi Luo, Xinghe Liang, Bin Zhou, Jinlin Hou, De-Ke Jiang

Antiviral Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective appraisal of clinical diagnostic algorithms for hepatocellular carcinoma surveillance in Chinese patients with chronic hepatitis B infection.
Henry L Y Chan, Yao Hu, Katharina Malinowsky, Kairat Madin, Konstantin Kroeniger, Jinlin Hou

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-HBc mirrors the activation of HBV-specific CD8 T cell immune response and exhibits a direct effect on HBV control.
Guofu Ye, Chengcong Chen, Yongjun Zhou, Libo Tang, Jianzhong Cai, Jinlin Hou

Antiviral Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early warning of hepatocellular carcinoma in cirrhotic patients by three-phase CT-based deep learning radiomics model: a retrospective, multicentre, cohort study.
Liangxu Guo, Xin Hao, Lei Chen, Yunsong Qian, Chunying Wang, Jinlin Hou

EClinicalMedicine· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An intronic genetic variant of ZHX2 predicts response to pegylated interferon α therapy in HBeAg-positive chronic hepatitis B patients.
Jia Hou, Chao Dong, Jiaxuan Chen, Haitao Chen, Rong Na, Jinlin Hou

Antiviral Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis